2023 – State Expert Center of the Ministry of Health of Ukraine

Patient leaflet on the use of the medicinal product OZURDEX®

20.12.2023 1359

Materials for patients for the medicinal product MABTHERA® (RITUXIMAB)

22.11.2023 1521

Communication materials for healthcare professionals and patients regarding the shortage of the medicinal product VICTOZA®

08.11.2023 1628

Communication materials for healthcare professionals and patients regarding the shortage of the medicinal product SAXENDA®

08.11.2023 1745

Updated additional risk minimization materials for the use of the medicinal product HUMIRA®

08.11.2023 1387

Patient materials on the safe use of the medicinal product LEFNO®

25.09.2023 1362

Mifenax® (mycophenolate mofetil)

10.07.2023 1656

CIBINQO

21.04.2023 1523

Patient educational card with safety information on the medicinal product Cibinqo (abrocitinib): contains warnings on the risk of infections, vaccination, thrombosis, pregnancy and contraception, and is intended for patients during treatment. generated automatically

ENTYVIO

19.04.2023 2003

Mitoxantrone «Ebewe

24.03.2023 1458

A guide for patients with multiple sclerosis receiving mitoxantrone: contains information on serious adverse reactions (heart disease, secondary acute myeloid leukemia), and the blood tests and cardiac examinations required before and during treatment. generated automatically

Patient leaflet on the use of the medicinal product OZURDEX®

Materials for patients for the medicinal product MABTHERA® (RITUXIMAB)

Communication materials for healthcare professionals and patients regarding the shortage of the medicinal product VICTOZA®

Communication materials for healthcare professionals and patients regarding the shortage of the medicinal product SAXENDA®

Updated additional risk minimization materials for the use of the medicinal product HUMIRA®

Patient materials on the safe use of the medicinal product LEFNO®

Mifenax® (mycophenolate mofetil)

CIBINQO

ENTYVIO

Mitoxantrone «Ebewe

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration